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Abstract
Background:  Chikungunya fever is an emerging arboviral disease characterized by an algo-
eruptive syndrome, inflammatory polyarthralgias, or tenosynovitis that can last for months to years.
Up to now, the pathophysiology of the chronic stage is poorly understood.
Case presentation: We report the first case of CHIKV infection with chronic associated
rheumatism in a patient who developed progressive erosive arthritis with expression of
inflammatory mediators and persistence of specific IgM antibodies over 24 months following
infection.
Conclusions: Understanding the specific features of chikungunya virus as well as how the virus
interacts with its host are essential for the prevention, treatment or cure of chikungunya disease.
Background
Chikungunya virus (CHIKV) is an enveloped positive-
strand RNA alphavirus which can infect human epithelial
and endothelial cells, fibroblasts or macrophages [1,2]. A
CHIKV epidemic recently occurred on islands of the
Indian Ocean in 2005 [3-5]. CHIKV infection may cause
an algoeruptive syndrome with disabling joint pain and
recurrent rheumatic manifestations [6-8]. Until now, it
has been assumed that complete recovery occurs, even
when symptoms are long lasting. Remarkably, despite the
severity and duration of arthritis, articular destruction has
been reported very rarely [9]. We report the case of a
patient with CHIKV infection presenting with severe
chronic rheumatism accompanied by progressive destruc-
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tive arthritis and dysregulated expression of inflammatory
mediators.
Case presentation
In November 2005, a 60-year-old French man living in La
Réunion experienced an acute influenza-like illness with
diffuse arthralgia affecting bilaterally the distal inter-
phalangeal joints of the fingers and the toes with hand
tenosynovitis. His past medical history was unremarkable
with no family history of inflammatory rheumatism.
Serology demonstrated the presence of anti-CHIKV IgM
and confirmed the diagnosis of CHIKV infection. During
the following months, the patient had persisting inflam-
matory arthralgia and joint stiffness which were not
improved by symptomatic treatment. One year later, he
developed refractory tenosynovitis in the wrists.
On February 15, 2007, the patient returned to France and
consulted in our department. He complained of persistent
symmetrical inflammatory arthritis of the wrists with
fixed oedema of the two hands predominating on the
right. Hand synovitis of the extensors and the flexors of
wrists and fingers were noted. Lymphocyte immunophe-
notyping showed an increased CD4 T-cell count at 1,18 ×
109/L (63.5%) and an activated CD45/CD3 (-) T-cell
count at 0.209 × 109/L (11.3%), and CD45/CD3 (+) at
0,119 × 109/L (6.4%). Serum immunoglobulin was nor-
mal, as were the C3 and C4 complement fractions. No
markers of autoimmunity were found, notably anti-citrul-
lin peptide antibodies, antinuclear antibodies or cry-
oglobulinemia. The HLA B27 gene was positive and HLA
system class II genotyping revealed an HLA-DRB1.03.11
genotype.
At the time of the consultation, serologic status for CHIKV
antibodies was reevaluated using IgM-capture and an IgG-
capture enzyme-linked immunoabsorbent assay with
inactivated cell-culture-ground chikungunya virus and
mouse anti-chikungunya hyperimmune ascitic fluid
(Institut Pasteur, Lyon, France). Persistent specific anti-
CHIKV IgM was detected in this late stage serum sample,
collected 18 months after the infection, with optical den-
sity (OD) values of 1.47 for IgG and 0.81 for IgM. Testing
for CHIKV RNA was negative [10]. Radiography of the
hands and wrists showed a subchondral defect of the 2nd
and 3rd right proximal interphalangeal finger joints as well
as of the 3rd, 4th and 5th left distal interphalangeal joints.
Magnetic resonance imaging (MRI) of the hands and
wrists revealed marked bilateral periostal inflammation
and oedematous carpitis (Fig 1A and 1B), with carpis syn-
ovitis (1C) and bone destruction in the left hand (1D)
accompanied by intra-articular swelling (1D). Bone scin-
tigraphy revealed diffuse inflammation of several joints,
prominent in the right wrist (3rd metacarpo-phalangeal
joint) (Fig 1E) and the left ankle (1F), as well as evolutive
enthesopathy of the left calcaneum. Methotrexate (MTX)
was initiated at the dose of 17.5 mg/week and four
months later, dramatic improvement was observed in
both the number and state of swollen and tender joints
and in tendon involvement. At this time, MRI of the
hands, wrists and feet showed reduced progression of ero-
sion and a decrease in radiographic inflammation and
oedematous damage compared to before treatment. Clin-
ical and radiological improvement was maintained over
15 months. At this end-point, CHIKV antibody serology
showed persistence of both specific IgM and IgG, with OD
values of 0.60 and 0.32, respectively.
Immunological evaluation
T cell function was assessed using proliferation assays and
ELISPOT quantification of interferon-γ (IFN-γ) produc-
tion by T cells. No proliferative response or IFN-γ produc-
tion could be detected in response to CHIKV antigens
derived from an in-house preparation of β-propionolac-
tone-inactivated virus (French Armed Forces Institute of
Tropical Medicine, Marseilles, France). T cell viability was
ascertained by concurrent detection in the same assays of
T cells responding to candidin and herpes simplex virus-1
antigens tested as controls.
Peripheral blood lymphocytes (PBL) from the patient and
from three healthy control individuals were isolated and
analysed at a transcriptomic level using real-time reverse
transcriptase-polymerase chain reaction (PCR) to detect
mRNA species encoding inflammatory mediators (RT2
Profiler™ PCR Array Human Inflammatory Cytokine and
Receptors, SuperArray, Frederick, USA). Each PCR used
the same quantity of total RNA from each cell culture and
the absence of a signal after 35 PCR cycles was taken as the
threshold for the mRNA not being detectable. These PCR
analyses were completed by measurement of cytokine lev-
els in the serum and in the 48 h PBL-derived supernatant.
These analyses were performed on samples obtained
before treatment initiation and at the four-month follow-
up.
At baseline, characteristic up regulation of mRNAs encod-
ing pro-inflammatory mediators, including TNF-α, LTA,
CRP, IL-1A and IL-17C was observed in PBL from the
patient (Table 1). In addition, these cells expressed high
levels of mRNAs encoding chemokines (IL-8, CCL1,
CCL7, CCL8, CCL16, CCL24, CCL26, and CXCL5) or
their receptors (XCR1, CCR2, CCR6, CCR8, and CCR9).
In contrast, the expression of genes encoding CD40 Lig-
and (CD40L), IFN-α, IL-22, CXCL2 and CXCL14 was not
detected. High levels of the pro-inflammatory cytokines
IL-1β, IL-6, IL-8 and IL-10 were detected in the superna-
tant following 48 h incubation of PBLs in culture medium
alone, while comparatively low levels of IFN-γ and TNF-αBMC Infectious Diseases 2009, 9:200 http://www.biomedcentral.com/1471-2334/9/200
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Magnetic resonance imaging (MRI) and bone scintigraphy of the hands and wrists of a 60-year-old man with chikungunya virus  infection revealing Figure 1
Magnetic resonance imaging (MRI) and bone scintigraphy of the hands and wrists of a 60-year-old man with 
chikungunya virus infection revealing. A. Arthritis of the 3rd metacarpo-phalangeal joint of the right hand with extensor 
tenosynovitis associated with intra-articular swelling (red arrow on axial section, time-resolved contrast-enhanced T1-
weighted sequence after Gadolinium injection with fat suppression) B. Bilateral periostum inflammation and oedematous carpi-
tis with synovitis predominating on the left hand (arrow on axial section, time-resolved-enhanced T2-weighted sequence with 
fat suppression) C. Asymmetric inflammatory carpitis with multiple synovitis of flexors of the left wrist (red arrows on axial 
section, time-resolved contrast-enhanced T1-weighted sequence after Gadolinium injection with fat suppression) D. Bone 
destruction on the left hand (red arrows on coronal section, time-resolved contrast-enhanced T1-weighted sequence with fat 
suppression) E. Bone scintigraphy of the wrists and hands showing an intense focus of technetium 99 m-labeled methylene dis-
phosphonate tracer uptake, particularly in the right metacarpo-phalangeal wrist. F. Bone scintigraphy of the left foot showing an 
intense focus of technetium 99 m-labeled methylene disphosphonate tracer uptake, particularly in the left ankle.BMC Infectious Diseases 2009, 9:200 http://www.biomedcentral.com/1471-2334/9/200
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TNF-α 241570 Tumor necrosis factor-α 
(TNFsuperfamily, member 2)
9† -15 -135
LTA 36 Lymphotoxin alpha 
(TNF superfamily, member 1)
1- 1 0 - 1 3
CRP 76452 C-reactive protein, pentraxin-
related
12 -3 -33
IL-1A 1722 Interleukin 1, alpha 2 -5 -9
IL-1F5 516301 Interleukin 1 family, member 5 
(delta)
84 1 -90
IL-1F6 278910 Interleukin 1 family, member 6 
(epsilon)
2- 9 - 2 0
IL-1F7 166371 Interleukin 1 family, member 7 
(zeta)
4- 3 - 1 1
IL-1F8 278909 Interleukin 1 family, member 8 
(eta)
7- 4 - 2 8
IL-1F9 211238 Interleukin 1 family, member 9 8 -2 -20
IL-1RN 81134 Interleukin 1 receptor antagonist 49 -3 -167
IL-9 960 Interleukin 9 3 -6 -20
IL-9R 406228 Interleukin 9 receptor 5 -3 -15
IL-17C 278911 Interleukin 17C 10 1 -10
SPP1 313 Secreted phosphoprotein 1 
(osteopontin, bone sialoprotein I, 
early T-lymphocyte activation 1)
7- 2 - 1 5
C3 529053 Complement component 3 12.25 19 1
Th2-related factors
IL-13 845 Interleukin 13 5 -11 -55
IL-22 287369 Interleukin 22 OFF OFF --
CD40L 592244 CD40 ligand 
(TNF superfamily, hyper-IgM 
syndrome)
OFF OFF --
Inflammatory chemokines and their receptors
IFN-α 211575 Interferon-α2 OFF OFF --BMC Infectious Diseases 2009, 9:200 http://www.biomedcentral.com/1471-2334/9/200
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were found. On the contrary, IFN-α, IL-4 or IL-5 were not
detected in cell supernatant (Table 2).
Four months following initiation of treatment, the expres-
sion of most of the above mRNAs was attenuated, and
expression of CD40L, IFN-α and IL-22 remained undetec-
table. At this time, cytokine levels measured in the cell cul-
ture supernatant were markedly decreased and surface
CD40L expression on peripheral blood cells could not be
detected (data not shown).
Conclusions
Chikungunya virus infection is usually a self-limiting dis-
ease characterized by arthralgia with late peripheral joint
pain in the smaller joints [11,12]. A sole case of late artic-
ular destruction after decades of post CHIKV-chronic
rheumatism has been reported with a questionable rela-
tionship to the CHIKV infection [9]. Our case is remarka-
ble for the clearly erosive arthritis pattern accompanied
with enthesopathies, which developed within less than
two years of the index CHIKV infection [13].
The patient was positive for HLA B27 antigen although no
clinical rheumatologic manifestations had been noted
before the CHIKV infection. For this reason, we can con-
clude that he developed a form of spondylarthropathy.
Concerning the acute phase, recent findings suggested
that both classical and severe symptoms of chikungunya
disease closely reflect CHIKV tissue tropism [14], with
fibroblasts being the primary targets, as they are for other
alphaviruses [1,15]. The molecular basis of this tropism
may combine specific interactions between virus and host
cells and tissues, and an intrinsic lower ability of this cell
type to control CHIKV infection [8,14].
The pathogenesis of persistent arthritis remains unclear
although persistent infection of synovial macrophages has
been documented for other alphaviruses [16,17]. Moreo-
IL-8 624 Interleukin 8 5 1 -5
XCR1 248116 Chemokine (C motif) receptor 1 34 -2 -62
CCL1 72918 Chemokine (C-C motif) ligand 1 4 -31 -109
CCL7 251526 Chemokine (C-C motif) ligand 7 3 -14 -40
CCL8 271387 Chemokine (C-C motif) ligand 8 2 -46 -80
CCL16 10458 Chemokine (C-C motif) ligand 16 6 -3 -22
CCL24 247838 Chemokine (C-C motif) ligand 24 76 -3 -190
CCL26 131342 Chemokine (C-C motif) ligand 26 7 -2 -15
CCR2 644637 Chemokine (C-C motif) receptor 2 13 89 7
CCR6 46468 Chemokine (C-C motif) receptor 6 4 -5 -17
CCR8 113222 Chemokine (C-C motif) receptor 8 8 -2 -19
CCR9 225946 Chemokine (C-C motif) receptor 9 5 -3 -15
CXCL2 590921 Chemokine (C-X-C motif) 
ligand 2
OFF 2 ON
CXCL5 89714 Chemokine (C-X-C motif) ligand 5 27 4 -7
CXCL14 483444 Chemokine (C-X-C motif) 
ligand 14
OFF 1 ON
Patient had persistent specific IgM antibodies and erosive arthritis for two years before treatment.
† gene expression in patient peripheral blood mononuclear cells compared to those observed in cells from three healthy controls using real-time 
RT-PCR. Results shown as fold expression compared to control values. Inflammatory arrays were performed using RT2 Profiler PCR Array System 
(Ref: APHS-011B, SuperArray, Frederick, USA, http://www.superarray.com
†† Comparison of gene expression before MTX treatment and following 4 months therapy
Table 1: Gene expression profile in a patient with chikungunya virus infection before and four months following methotrexate (MTX) 
treatment. (Continued)BMC Infectious Diseases 2009, 9:200 http://www.biomedcentral.com/1471-2334/9/200
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ver, factors secreted by infected macrophages seem to play
a pivotal role in joint inflammation [18]. To date, the
presence of CHIKV RNA in joints during the acute phase
of infection has only been demonstrated in animal mod-
els [14,19]. CHIKV RNA has never been detected in joint
tissues during the late phase, although it has been found
in human muscle satellite cells three months after infec-
tion [2]. Taken together with reports of the presence of
long lasting IgM anti-CHIKV antibodies [20], these find-
ings could indicate the persistence of CHIKV in certain
host tissues or cells. However, there is no evidence that
viral persistence is necessary to sustain chronic joint
pathology after the infection. In our case, an antigen-spe-
cific immunopathology may underlie the development of
chronic joint disease due to the presentation of specific
autologous or microbial arthritogenic peptides [21]. This
would be consistent with the notion of an infectious trig-
ger for immune activation derived from molecular mim-
icry which has been postulated as a potential pathogenic
mechanism in autoimmunity [22-24].
High levels of pro-inflammatory cytokines IL-1, IL-6 and
IL-8 were detected in cell supernatants from the patient's
lymphocytes and elevated expression of genes encoding a
variety of cytokines and chemokines known to be impli-
cated in the pathogenesis of arthritis were also observed
[25,26]. In contrast, IFN-α, IL-4 and IL-5 were not
detected in cell supernatants whereas IL-10 was increased.
Of interest, the lymphocytes failed to express genes encod-
ing IFN-α, IL-22 and CD40L, which are required for B cell
differentiation, optimal immunoglobulin isotype switch-
ing and antiviral activity. Although the persistence of spe-
cific IgM antibodies has been documented after CHIKV
infections [20], an association between these antibodies
and disease severity has not been established. It is possible
that antibody persistence may be determined by the per-
sistence of virus in host tissues since, in acute arboviral
infections, IgM are generally no longer detectable after 6-
12 months. Unfortunately, in our case, it was not possible
to perform RT-PCR for detection of CHIKV in synovial
fluid or tissue
Viruses have evolved a number of mechanisms for sup-
pressing host immune responses. In particular, viral pro-
teins may suppress the retinoic acid-inducible gene I-like
helicase and Toll-like receptor pathways important for the
expression of type 1-IFNs, such as IFN-α isoforms, which
play a crucial role in eliminating viral infections [14,27-
29]. Immunoglobulin class switching from IgM to IgG
and IgA is central to immunity against viruses and
requires the activation of B-cells by T-cells via cytokine
interactions with CD154/CD40L. Mutations in the
CD40L gene have been observed in cases of inherited
hyper-IgM X-linked immunodeficiences [27]. In this con-
text, CHIKV may be able to evade T-cell dependent IgG
and IgA responses by attenuating CD40L gene expression.
Such a mechanism has been postulated previously to
explain hyper IgM syndrome associated with various viral
infections [30-32].
We report here a case of CHIKV infection with joint and
bone erosion and persistent specific IgM nearly two years
following infection. Transcriptomic and protein analysis
revealed individual genes which could be implicated in
the pathogenesis of chronic arthritis; these genes have not
been associated previously with alphavirus-induced
arthritis.
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